Genic Co Ltd
Genic Co Ltd is a personal products company that operates in the consumer non-cyclicals sector, focusing on personal care and household products.
Business. Genic Co Ltd (123330.KQ) is a South Korean company engaged in the personal products industry, operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items and is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue breakdowns are not disclosed in the available data.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Genic Co Ltd (123330.KQ) is a South Korean company engaged in the personal products industry, operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items and is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue breakdowns are not disclosed in the available data.
- Genic Co Ltd has no dilution from stock options or convertible instruments, as the basic and diluted share counts are identical.
- Analysts have issued a strong buy recommendation for Genic Co Ltd, with a mean price target of 42,000 KRW.
- Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
- No profitability or returns data is available for comparison with industry benchmarks.
- No segment or geographic exposure details are disclosed, limiting visibility into revenue concentration.
- No growth trajectory data is available for the current or next fiscal year.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Genic Co Ltd Market data — financials · 2026-05-26
- Genic Co Ltd Market data — analyst estimates · 2026-05-26